Application no. and date | 20161276.9 (espacenet) (Federated) (European Patent Register), 20180105 | Patent/reg. no. and date | DK/EP 3722415, 20241106 | Publication date | 20201014 | Priority no. and date | US 201762478506 P, 20170329, US 201762539410 P, 20170731, US 201762548306 P, 20170821, US 201762554538 P, 20170905, US 201762559374 P, 20170915, US 201762567121 P, 20171002, US 201762577655 P, 20171026, US 201762582874 P, 20171107, US 201762596374 P, 20171208 | EP pub. no. and date |
EP 3722415 20201014 | Effective date | | Applicant/owner | Iovance Biotherapeutics, Inc., 825 Industrial Road Suite 400
San Carlos, CA 94070, US | Applicant ref. no. | V2412-035-DK | Inventor | LOTZE, Michael, T., 5134 Westminster Place
Pittsburgh, PA 15232, US, BENDER, James, 3 Cloverdale
Rancho Santa Margarita, CA 92688, US, WARDELL, Seth, 30204 USF Holly Drive
Tampa, FL 33620, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | C12M 1/04 (2006.01) , C12N 5/0783 (2010.01) | Title | FREMGANGSMÅDER TIL FREMSTILLING AF TUMORINFILTRERENDE LYMFOCYTTER OG ANVENDELSE HERAF I IMMUNTERAPI | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|